Hypoxemia is a common complication of the diseases associated with the central nervous system, and neurons are highly sensitive to the availability of oxygen. Neuroplasticity is an important property of the neural system controlling breathing, memory, and cognitive ability. However, the underlying mechanism has not yet been clearly elucidated. In recent years, several pieces of evidence have highlighted the effect of hypoxic injury on neuronal plasticity in the pathogenesis and treatment of mood disorder. Therefore, the present study reviewed the relevant articles regarding hypoxic injury and neuronal plasticity and discussed the pathological changes and physiological functions of neurons in hypoxemia in order to provide a translational perspective to the relevance of hypoxic injury and mood disorder.
Natural Science Foundation of China3147112031540076311711231. Introduction
The ability of the brain to absorb internal and external information, learn new skills, and form new memories is dependent on neural functions. Neurons are the fundamental structural and functional units in the neural information network. The neural plasticity might be an ability of the nervous system to adapt in response to intrinsic and extrinsic stimuli [1]. A large number of studies demonstrate that neural circuits, synaptic connections, morphology, and the biochemical components (including nucleic acids, enzymes, and neurotransmitters) of a single neuron may exhibit a certain degree of plasticity. This phenomenon explicates why dysregulation or disruption of neural plasticity may be associated with neurodegenerative and neuropsychiatric disorders, such as mood disorders. Mood disorders are known as mental disorders characterized by periodic elevation of the mood, which might sometimes alternate with the periodic depression. The pathogenesis of mood disorders is yet uncertain, and the role of neural plasticity in mood disorder has been widely evaluated.
Recently, a large number of factors have been identified that can affect neural plasticity; the correlation between hypoxic injury and neural plasticity has been under intensive focus. In this article, we review some of the recent studies on the relationship of hypoxic injury and neural plasticity in mood disorders and explore the mechanism underlying the hypoxic damage leading to mood disorders.
2. The Main Mechanism of Hypoxic Injury
Hypoxemia refers to insufficient oxygen in the circulating blood. However, the general term hypoxia indicates an abnormally low concentration of oxygen in any tissue, organ, or the body as a whole. Hypoxia has been implicated in a large number of pathologies, including head trauma, stroke, neurodegenerative diseases, obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD), which are related to the central nervous system (CNS) and respiratory system. Thus, any factors that affect the volume or rate of oxygen reaching the lungs or any causes that lessen the transfer of oxygen from the lungs to the blood might result in hypoxemia. The brain is highly sensitive to the oxygen concentration in the artery [2]. Any disease that affects the airflow and blood perfusion could cause decreased oxygen supply to the brain [3] that might alter the neuronal function, leading to cell injury and death. Spatial memory and learning deficits caused by long-term intermittent hypoxia (IH) are accompanied by an increase in oxidative stress in the brain areas, such as the hippocampus, involved in cognition and memory [4]. Hypoxia causes the enhanced anaerobic glycolysis in cells [5, 6], which led to aberrant oxidative phosphorylation and energy supplement in cells. In addition, patients with COPD and obstructive sleep apnea are often accompanied by systemic inflammation [7, 8], which might aggravate the neuronal damage. Hypoxia-induced neurodegeneration and apoptosis may also play a vital role in mood disorder. Protocatechuic acid (PCA) was noted to alleviate the oxidative stress, apoptosis, and glial proliferation; moreover, it also decreased the level of IL-1β in the brain following chronic intermittent hypoxia, further enhancing the learning and memory ability [9].
In addition, ischemia is commonly a restriction in blood supply to tissues, which result in the deficiency of glucose and oxygen needed for cellular metabolism. Ischemia includes insufficiency of oxygen, decreased availability of nutrients, and inadequate discharge of metabolic rubbish. Both hypoxic injury and ischemic damage effectuate in coordination during the pathogenic process of different diseases, such as stroke.
2.1. Oxidative Stress
Oxidative stress is caused by increased production of both reactive oxygen species (ROS) and reactive nitrogen species (RNS) or decreased antioxidant ability and the capacity of elimination of free radicals. When the oxygen supply is not sufficient, the electron transport chain is impeded, and oxygen radicals and peroxynitrite can be produced, including hydrogen peroxide, superoxide, perhydroxyl, and hydroxyl radicals. This process can be aggregated by Ca2+ accumulation in the mitochondria that results in mitochondrial dysfunction which, in turn, increases the production of reactive oxygen radicals. All these ROS/RNS can alter the structure of DNA by direct interaction and lead to cell injury and apoptosis [10]. Hypoxia also induces the cells to undergo oxidative stress from the uncontrolled generation of ROS in the mitochondrion that might lead to cell death in the tissue [6, 11, 12]. The hypoxia and ischemia-reperfusion injury are severe in some brain injury patients; the abundant production of ROS/RNS and inadequate supply of antioxidants is primarily responsible for the subsequent brain pathology, as the balance between the oxidative and antioxidative systems is disrupted in the brain [13, 14]. However, the chronic intermittent hypoxia (CIH) is shown to occur in the respiratory diseases, causing an increase in ROS/RNS and the overall oxidative stress [13, 14]. Furthermore, oxidative stress is associated with the development of CNS diseases involving cognitive function and memory processes [15–17], such as hippocampal synaptic plasticity. Hypoxia-induced oxidative stress also contributes to neurodegeneration and apoptosis [18], as well as spatial memory impairment [11].
2.2. Systemic Inflammation
Systemic inflammation is crucial for the mechanism of hypoxic brain injury [19, 20]. The acute and chronic inflammation event that occurs during and following hypoxia may be involved in secondary neuronal injury processes [10]. The process of inflammation is characterized by the infiltration of inflammatory cells, production of inflammatory mediators, and activation of resident cells. The activation and infiltration of inflammatory cells into a functional brain area is the interactive effect of a series of adhesion molecules, chemokines, and cytokines. The cytokines involved in the process of hypoxic injury include tumor necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β), interleukin-6 (IL-6), and other factors. Various cytokines and chemokines have been produced and released during the inflammatory process; furthermore, neutrophils, macrophages, T cells, and other cells, have been activated, which could aggravate the secondary injury of the tissue [10]. The prognosis of acute and prolonged inflammatory process in the brain may be different depending on the ether interaction between the inflammatory cells and mediators or the compensatory capacity of the body.
Overall, the chronic systemic inflammation may result in cognitive function impairment by the following aspects: (1) persistent activation of microglia induces neuronal injury [21]; (2) inflammation leads to the morphological changes in neuronal dendritic spines in susceptible regions in the brain [22]; and (3) inflammation downregulates the expression of the genes associated with growth factors that are involved in cognitive and memory ability [22].
2.3. Apoptosis
Apoptosis is a genetically programmed cell death occurring at specific developing stages in plants and animals; it is an active death-related process of the cells and is controlled by specific genes [23, 24]. The biochemical events lead to characteristic morphological changes and death in the cells. These characteristic changes include cell blebbing, cell shrinkage, nuclear chromatin condensation and fragmentation, chromosomal DNA fragmentation, and mRNA decay [10]. In normal physiological conditions, apoptosis is a homeostatic mechanism maintaining the cells in different tissues. Apoptosis also occurs as a protective response in the case of cell damage in abnormal pathological conditions. Apoptosis is an energy-dependent coordinated process that involves the activation of a series of cysteine proteases and a complex cascade of events that link the initiating stimuli to the final cell death [23]. In some cells, radiation treatment can lead to apoptosis through a p53-dependent pathway-mediated DNA damage, as well as other cellular apoptosis reactions induced by expressing Fas or TNF receptors [23]. A recent study suggests that delayed hyperbaric oxygen can enhance neurogenesis and improve neuronal function by ROS/HIF-1α/β-catenin pathway [25].
2.4. Endoplasmic Reticulum and Excitotoxicity
The endoplasmic reticulum (ER) is a locus where proteins are modified, folded, and calcium-modulated. Reportedly, ER can prevent oxidative stress and aberrant Ca2+ regulation from killing the neurons in vivo and in vitro [26–28]. ER stress is initiated in the early stage of hypoxic-ischemia, and the activation of ER stress response is a grave consequence of enhanced oxidative stress, which could result in a series of cellular malfunctions as well as neuronal apoptosis [29, 30]. ER stress can cooperate with autophagy in the process of neurodegeneration with the morphological changes in the ER structure [31]. Regular exposure to the intermittent hypoxic environment can cause dilation and distortion of ER in the hippocampus of mice that is accompanied by excessive expression of Grp78 [32], caspase-12, and CHOP; caspase-12 and CHOP are the two mediators associated with ER-induced apoptosis [33, 34].
CIH exposures lead to upregulation of the unfolded protein response (UPR) in the brain prefrontal cortex and hippocampus by enhanced phosphorylation of PKR-like ER kinase, which indicates that a specific ERS inhibitor, salubrinal, protects the neurons against CIH-induced injury [35]. The short-lasting activation of UPR can prevent its further accumulation by inhibiting the synthesis of protein, and the sustained activation of UPR might be associated with the neurodegeneration in hypoxia-ischemia [36].
Thus, the above findings suggest that ER is a valuable biomarker of the severity of hypoxia-ischemia injury.
3. Hypoxic Injury and Neuronal Plasticity
The brain is highly sensitive to the change in the arterial concentration of oxygen [2]; it ineluctably sustains the hypoxic stress. Decreased oxygen content might lead to neuronal injury in the brains of COPD patients, which is demonstrated by clinical symptoms such as mood disorders and neuropsychological deficits [3]. Furthermore, the systemic inflammation is accompanied by a hypoxic injury that may exacerbate the neuronal injury. A large number of patients with intermittent hypoxia manifest a series of symptoms related to the injury to the nervous system, which is exhibited as a deficiency in memory, learning, and decision-making ability [37]. In addition, the hypoxic damage in the brains of other patients is manifested as depression, anxiety, physical disabilities [7], and neuropsychological deficits [2, 38–41]. Compared to the controls, patients with COPD displayed a poor performance in the figure memory test, mini-mental state examination, and visual reproduction [3]. Some studies demonstrate that hypoxia is associated with the changes in the brain structure, including volume atrophy and a decrease in the gray matter in the amygdala, hippocampus, anterior cingulate cortex, prefrontal cortex, and other regions [42, 43]. Different degrees of IH-induced irreversible damage to the neural cell ultrastructure and loss of nerve cells, which could cause various degrees of nervous system disorders. The neuronal plasticity plays a critical role in brain function. The hypoxic injury affects the neuronal plasticity in the brain through different mechanisms, thereby affecting the brain in response to intrinsic and extrinsic stimuli. Moreover, several regions of the brain, such as the hippocampus, frontal cortex, amygdala, insula, anterior cingulate, fornix, mammillary bodies, and cerebellum, are impaired during and after sleep-disordered breathing, and all these structures are altered in depression patients [44]. The different kinds of changes of neural plasticity induced by hypoxic-ischemic injury in various brain regions are shown in Table 1.
Changes of neural plasticity induced by hypoxic-ischemic injury in various brain regions.
Brain region
Changes of neural plasticity
Mechanisms
Hippocampus
Synaptic plasticity
(1) Triggering of LTD via ROS and NOS
(2) Impairment of LTP in presynaptic neurons
(3) Impaired synaptic transmission and plasticity in dentate gyrus area of rats
(4) Fine structural changes of synapses in CA1 region
Volumetric changes
(1) Hippocampal atrophy and neurons apoptosis
(2) White matter density decreased
Apoptosis
(1) A severe loss of neurons induced by activation of MAPK signaling pathways
(2) ER stress and oxidative stress
Misfolded/unfolded protein
(1) Increased production of ROS
Prefrontal cortex
Synaptic plasticity
(1) Increased density of the GABAergic neurons impair the network activity within PFC
(2) Increased neuronal death
(3) Activation of T-type Ca2+ channels in the MD
Activity in vmPFC and dlPFC
(1) Increasing the acetylcholine release by enhancing the activation of G protein
Immunoreactive cells and cytokine changes
(1) Upregulated expression of molecules such as VEGF, Hif-1, and Glut1
(2) PV cells loss induced by the NOX2-derived oxidative stress
Volumetric changes
(1) Increased neuronal death and ghost cells
(2) Tissue atrophy
Amygdala
Synaptic plasticity
(1) Decreased expression of NPY
(2) Increased expression of c-fos protein
Volumetric changes
(1) Smaller gray matter volume in the amygdala and decreased volume of the left amygdala
(2) Significant shrinkage of cell size and axonal degeneration of corticotropin-releasing factor-positive neurons
Signaling pathways
Upregulation of Abcc1, Abcc2, and Abcc4 mRNA expression at the BBB
(1) Regulated through Nrf2 signaling
Activation of BDNF-TrkB signaling pathway
(1) The circulating levels of BDNF increased
Enhancement of ERK1/2-CREB-BDNF signaling pathway
(1) The circulating levels of BDNF increased
Activation of STAT3 signaling pathway
(1) Phosphorylation of STAT3
Triggering cAMP/PKA signaling pathway
(1) Increased release of CRF
Dysregulation of NMDARs-Wnt-catenin signaling
(1) Decreased expression of NMDARs
3.1. The Hypoxic Injury in the Hippocampus
In the brain, the hippocampus has an affinity with learning and memory, and the hippocampal synapse is a model system to study the mechanisms of learning and memory [45]. The hippocampal synaptic plasticity is considered as important for the formation of hippocampus-dependent explicit memory [46]. A previous study on quantum dots proved that nanoparticle impaired the synaptic transmission and plasticity in the hippocampus dentate gyrus area of rats via oxidative stress [47]. The long-term synaptic plasticity is an essential property of the nervous system and a critical mechanism for memory and learning, which can bidirectionally modify the synaptic strength—either depressing (long-term depression (LTD)) or enhancing (long-term potentiation (LTP)) [48]. Some studies show that NO affects the hippocampal synaptic plasticity, including LTD and LTP, and consequently learning and memory [49–54]. Also, NO serves as a retrograde messenger and acts directly on the presynaptic neurons to produce LTP [48, 55–57] and then suppresses the synaptic plasticity [58]. Other studies have shown that some drugs could protect the hippocampal neurons by inhibiting the NOS activity and expression in the hippocampus [58–60]. The ER stress induced by chronic IH resulted in apoptosis and fine structural changes in the synapses in the hippocampal CA1 region [61], which might inhibit the transfer of Schaffer collaterals from CA3 to CA1 neurons [62]. Hypoxia and inflammation act in synergy to trigger the long-term synaptic depression (LTD), which might contribute towards synaptic disruptions and memory impairments in neuroinflammation-related brain disorders [63].
MAPK phosphorylation is enhanced following IH. The overstimulation of MAPK signaling pathways by IH induces the abnormal expression of Bax and Bcl-2, resulting in a severe loss of hippocampal neurons. This phenomenon was correlated to oxidative stress, inducing the upregulation of malondialdehyde (MDA) and the downregulation of superoxide dismutase (SOD) [64]. Accumulating evidence demonstrate that the production of ROS is closely related to protein folding [65, 66], and the accumulation of misfolded or unfolded protein could cause increased ROS production [29]. The present study suggests that the aberrant energy metabolism might be an alternative mechanism underlying depression.
In addition, the volumetric changes of the hippocampus are also critical to mood regulation. Reportedly, the cognitive disabilities in hypoxia-ischemic encephalopathy patients are also accompanied by hippocampal atrophy; the white matter density is decreased in the frontal gyrus [67, 68]. In the event of hypoxia induced by central hypoventilation syndrome (CHS), the hippocampus shows a reduced volume [69]. Smaller hippocampal volumes have also been reported in schizophrenic individuals who suffered pre- and perinatal hypoxia [70]. Additionally, some studies postulate that hippocampal apoptosis is a causative factor in hippocampal volumetric changes [71].
3.2. The Hypoxic Injury in the Prefrontal Cortex
The prefrontal cortex (PFC) is a crucial nerve center of thinking and behavior regulation in the brain [72] and is divided into two subregions: ventromedial prefrontal cortex (vmPFC) for regulating the affection and dorsolateral sectors (dlPFC) for mediating the cognitive functions [73, 74]. The interactions within the neuronal networks centered on the hippocampus and PFC are closely related to information transfer and storage [75–77]. The PFC receives strong monosynaptic projections from the intermediate and ventral hippocampus [78, 79]. The hypoxia-ischemic injury causes the disruption of interactions within the prefrontal-hippocampal networks [80], which could affect the thinking and behavior. Several studies reported that the frontal lobe dysfunction led to various degrees of cognitive impairments such as inattention, hyperactivity, impulsiveness, and changes in the personality [81].
PFC is a region contributing towards the behavioral regulation and neuroendocrine responses to stress and can be injured by excessive exposure to a stimuli-induced release of inflammatory mediators and steroid molecules [82–84]. A previous study reported that animals exposed to IH presented impaired executive function associated with dopaminergic disturbance and tissue atrophy in the PFC [85]. The increased density of GABAergic neurons in the PFC during and after IH disrupts the balance between excitation and inhibition which, in turn, impairs the network activity within PFC [80]. Since the thalamic burst spikes are efficient in exciting the postsynaptic neurons [86], the activation of T-type Ca2+ channels in the MD might specifically stimulate the PFC neurons and then lead to frontal lobe-specific seizures [81]. In the mouse model, PFC damage induced by hypoxic conditions including ghost cells, increased the neuronal death and upregulated the expression of molecules such as VEGF, Glut1, Hif-1, and lactate dehydrogenase A, which might cause a local excitability in PFC neurons [81, 87]. In addition, NADPH oxidase-2 induced the oxidative stress that might contribute to the developmental loss of parvalbumin- (PV-) positive cells (PV-cells) in the PFC and progression of psychiatric anxiety in rat models [72, 88]. Moreover, the loss of PV-cells in the PFC and the IH-induced psychiatric anxiety can be alleviated by inhibiting the NADPH oxidase-2-induced oxidative stress [88].
Acetylcholine is an indispensable element for memory and learning [89]. IH could induce spatial learning deficits, and the expression of choline acetyltransferase in the basal forebrain decreased in rats [90, 91]. Muscarinic cholinergic receptors are coupled to G proteins [92], and M2-muscarinic receptor regulates the release of acetylcholine in PFC in mouse [93]. G proteins constitute a functionally complex network that enhances the transmembrane signaling. A few changes in the activation of G proteins can dramatically cause distal signal transduction cascades. Hypoxia enhanced the cholinergic activation and mu-opioid activation of G proteins in the PFC, thereby increasing the acetylcholine release of PFC neurons; thus, the functions of PFC is altered [94].
3.3. The Hypoxic Injury in the Amygdala
The amygdala is closely associated with emotion, learning, attention, and memory, especially its role in the correlation between negative emotion and learning ability as well as memory [95]. The disturbances to the amygdala constitute the primary features of bipolar disorder [96]. The various changes in the morphology and function of amygdala might be related to mood disorders such as depression [97, 98]. The hypoxic injury arising from diverse factors might cause serious changes in the amygdala and has been demonstrated in several animal models. Carty et al. found a significant decrease in the cell size and axonal degeneration of corticotropin-releasing factor-positive neurons in the amygdala of the rat after undergoing neonatal hypoxia-ischemia [99]. The gray matter in the amygdala is reduced in children who suffered from neonatal hypoxia-ischemia [100], and the volume of the left amygdala is reduced in patients with COPD [3]. The number of corticotropin-releasing factor- (CRF-) and neuropeptide-Y- (NPY-) positive neurons were found to be decreased distinctly in the amygdala after postnatal day 3 hypoxia-ischemia [99], and c-fos protein expression increased in the nc. accumbens and the anterior amygdaloid area in the rat brain exposed to hypoxic injury [101]. These long-term changes in the amygdala may be functionally associated with the specific behavioral disorders including bipolar disorder [102].
However, some researchers found that perinatal hypoxia does not change the susceptibility to amygdaloid-induced seizures in the adult rabbits [103].
3.4. The Hypoxic Injury in Other Structures of the Brain
Heart failure (HF), OSA, and congenital central hypoventilation syndrome (CCHS) occur as a result of insular and cingulate cortex injury [62]. Damage in those regions apparently contributes towards inhibiting or enhancing the sensation. The extent of injury in the insula shows the loss of tissue in HF, increased mean diffusivity in OSA, and axial and radial diffusivity changes in CCHS as well as in anterior cingulate [62]. Other studies have shown that the cortical thinning and white matter loss also occurs in the brain after the repeated chronic exposure to hypoxia and hypercapnia in CHS [104, 105]. Based on the fMRI study, significant differences were observed in the magnitude and timing of responses in specific regions of the brain between groups induced by hypoxia; these regions included the cerebellar cortex, deep nuclei, and posterior thalamic structure, as well as the amygdala and hippocampus. These finds emphasize the important roles of posterior thalamus, midbrain, and cerebellum in normal hypoxic conditions [106].
3.5. The Related Signaling Pathway in Hypoxia/Hypoxic-Ischemia Injury
Several pathways, regulators, and effectors participate in the pathological process of the secondary injury of brain hypoxia/hypoxia-ischemia reperfusion. The damage to blood-brain barrier (BBB) also plays a critical role in the initiation of the reoxygenation/reperfusion injury and development.
Hypoxia/reoxygenation (H/R) stress can induce the upregulation of the mRNA expression of Abcc1, Abcc2, and Abcc4 at the BBB. This upregulation is regulated by the activation of nuclear factor E2-related factor (Nrf2) signaling. The Mrp isoforms belong to the ABCC group of proteins, and the enhanced functional expression of Mrp isoforms at BBB could induce the neural cell injury and death by reducing the concentrations of antioxidant glutathione (GSH) in the endothelial cell [107]. Another study demonstrated that the upregulation of Nrf2 by hyperbaric oxygen preconditioning (HBO-PC) might alleviate the hypoxia-ischemia brain damage (HIBD) [108]. Brain-derived neurotrophic factor (BDNF) is another critical molecule that promotes the growth and survival of nervous cells as well as the communication between neurons. In addition, it plays a major role in long-term memory and cognitive function. The circulating levels of BDNF in humans have been shown to increase dramatically during hypoxic stress, both in the perinatal period [109] and adulthood [110, 111] which, in turn, inhibits the ER stress activation as well as ROS production [112]. BDNF can regulate the ion channel activity and synaptic transmission in different regions of the brain by interacting with the TrkB receptor [113]. BDNF-TrkB signaling pathway has a precedent role in modulating the synaptic plasticity in the CNS [114]. During chronic hypoxia, the activation of BDNF-TrkB signaling pathway increases the voltage-dependent Ca2+ influx and catecholamine secretion in chromaffin cells [114]. Furthermore, CIHH pretreatment improved the ischemia-induced cognitive dysfunction by the activation of ERK1/2-CREB-BDNF signaling pathway [115].
As demonstrated above, BDNF not only plays a crucial role in the development of CNS but also regulates the plasticity of neurons during hypoxic stress.
STAT3 signaling pathway has also been shown to play a role in the hypoxic injury of neural cells. The hypoxic-ischemia damage may cause the phosphorylation of STAT3, and the activation of STAT3 signaling pathway might be involved in the apoptosis-mediated regulation of nerve cells [116], tissue loss, and gliosis following neonatal hypoxia-ischemia stress [117]. Hypoxia triggers cAMP/PKA signaling pathway in cortical astrocytes by releasing CRF, thereby leading to the activation of aquaporin-4 and cerebral edema [118]. In addition, the dysregulation of N-methyl-D-aspartate receptors (NMDARs)-Wnt-catenin signaling in the hippocampus may participate in the process of prenatal hypoxia that induces the spatial acquisition and retrieval deficits in adolescent offspring [119].
4. Summary and Conclusion
Neuronal plasticity is a critical property of the neural system regulating and coordinating mood and behavior. There are various intrinsic and extrinsic stimuli, which could affect the neuroplasticity in several aspects, such as the volume of nuclei, regulation of neuronal apoptosis and neurodegeneration, secretion of neurotransmitter, and any other forms of changes. Oxidative stress, inflammation, apoptosis, and excitotoxicity are the primary mechanisms underlying hypoxic-ischemic brain injury [10]. Various degrees of improvements were found in oxidative stress markers, cell density, the rate of neuronal apoptosis, and caspases in hypoxia-ischemia model of the rat after treatment with hyperbaric oxygen [120] and antioxidants. The goal was to explore the mechanism of hypoxic injury on the brain in order to focus on the long-term functional recovery in both injured and uninjured brain regions, and the neuronal plasticity might serve as the vital target.
Conflicts of Interest
The authors confirm no conflict of interest with respect to the present study.
Acknowledgments
This work was supported by grants from the Natural Science Foundation of China (NSFC: 31471120, 31540076, and 31171123).
WainwrightS. R.GaleaL. A.The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus20132013141480549710.1155/2013/8054972-s2.0-848772875172369137184877287517ErecińskaM.SilverI. A.Tissue oxygen tension and brain sensitivity to hypoxia2001128326327610.1016/S0034-5687(01)00306-12-s2.0-0035160270117187580035160270ZhangH.WangX.LinJ.SunY.HuangY.YangT.ZhengS.FanM.ZhangJ.Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study201334233433910.3174/ajnr.A32352-s2.0-848759631382285927784875963138Abdel-WahabB. A.Abdel-WahabM. M.Protective effect of resveratrol against chronic intermittent hypoxia-induced spatial memory deficits, hippocampal oxidative DNA damage and increased p47Phox NADPH oxidase expression in young rats2016305657510.1016/j.bbr.2016.02.0302-s2.0-849608498362694060484960849836KimJ. W.TchernyshyovI.SemenzaG. L.DangC. V.HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia20063317718510.1016/j.cmet.2006.02.0022-s2.0-336446145201651740533644614520PapandreouI.CairnsR. A.FontanaL.LimA. L.DenkoN. C.HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption20063318719710.1016/j.cmet.2006.01.0122-s2.0-336446225701651740633644622570BarnesP. J.Chronic obstructive pulmonary disease: effects beyond the lungs201073, article e1000220LimD. C.PackA. I.Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier2014181354810.1016/j.smrv.2012.12.0032-s2.0-848901766172354156284890176617YinX.ZhangX.LvC.LiC.YuY.WangX.HanF.Protocatechuic acid ameliorates neurocognitive functions impairment induced by chronic intermittent hypoxia2015514507QuillinanN.HersonP. S.TraystmanR. J.Neuropathophysiology of brain injury201634345346410.1016/j.anclin.2016.04.0112-s2.0-849944388012752119184994438801MaitiP.SinghS. B.SharmaA. K.MuthurajuS.BanerjeeP. K.IlavazhaganG.Hypobaric hypoxia induces oxidative stress in rat brain200649870971610.1016/j.neuint.2006.06.0022-s2.0-337510677471691184733751067747DosekA.OhnoH.AcsZ.TaylorA. W.RadakZ.High altitude and oxidative stress20071582-312813110.1016/j.resp.2007.03.0132-s2.0-34548680780WangY.ZhangS. X.GozalD.Reactive oxygen species and the brain in sleep apnea2010174330731610.1016/j.resp.2010.09.0012-s2.0-78449285920LavieL.Obstructive sleep apnoea syndrome—an oxidative stress disorder200371355110.1053/smrv.2002.02612-s2.0-0037316130125865290037316130Farfan-GarciaE. D.Castillo-HernandezM. C.Pinto-AlmazanR.Rivas-ArancibiaS.GallardoJ. M.Guerra-AraizaC.Tibolone prevents oxidation and ameliorates cholinergic deficit induced by ozone exposure in the male rat hippocampus20143991776178610.1007/s11064-014-1385-02-s2.0-849398716662505242984939871666KellerJ. N.SchmittF. A.ScheffS. W.DingQ.ChenQ.ButterfieldD. A.MarkesberyW. R.Evidence of increased oxidative damage in subjects with mild cognitive impairment20056471152115610.1212/01.WNL.0000156156.13641.BA1582433916844382331WangJ.MarkesberyW. R.LovellM. A.Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment200696382583210.1111/j.1471-4159.2005.03615.x2-s2.0-336451066801640550233645106680ZhouB.LiM.CaoX.ZhangQ.LiuY.MaQ.QiuY.LuanF.WangX.Phenylethanoid glycosides of Pedicularis muscicola Maxim ameliorate high altitude-induced memory impairment2016157394610.1016/j.physbeh.2016.01.0372-s2.0-84956661605TobinM. K.BondsJ. A.MinshallR. D.PelligrinoD. A.TestaiF. D.LazarovO.Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here201434101573158410.1038/jcbfm.2014.1302-s2.0-84921718867IadecolaC.AlexanderM.Cerebral ischemia and inflammation2001141899410.1097/00019052-200102000-000142-s2.0-0035143182111762230035143182BlockM. L.ZeccaL.HongJ. S.Microglia-mediated neurotoxicity: uncovering the molecular mechanisms200781576910.1038/nrn20382-s2.0-338457687841718016333845768784JurgensH. A.AmancherlaK.JohnsonR. W.Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice201232123958396810.1523/JNEUROSCI.6389-11.20122-s2.0-848633898132244206384863389813ElmoreS.Apoptosis: a review of programmed cell death200735449551610.1080/019262307013203372-s2.0-342503083221756248334250308322MoskowitzM. A.LoE. H.Neurogenesis and apoptotic cell death200334232432610.1161/01.STR.0000054047.14853.AD2-s2.0-0037319338125745240037319338HuQ.LiangX.ChenD.ChenY.DoychevaD.TangJ.TangJ.ZhangJ. H.Delayed hyperbaric oxygen therapy promotes neurogenesis through reactive oxygen species/hypoxia-inducible factor-1α/β-catenin pathway in middle cerebral artery occlusion rats20144561807181410.1161/STROKEAHA.114.0051162-s2.0-849019111972475710484901911197FerrieroD. M.Neonatal brain injury2004351191985199510.1056/NEJMra0419962-s2.0-7444267966155257247444267966Puka-SundvallM.GajkowskaB.CholewinskiM.BlomgrenK.LazarewiczJ. W.HagbergH.Subcellular distribution of calcium and ultrastructural changes after cerebral hypoxia-ischemia in immature rats20001251-2314110.1016/S0165-3806(00)00110-32-s2.0-0034731384111547580034731384Chavez-ValdezR.FlockD. L.MartinL. J.NorthingtonF. J.Endoplasmic reticulum pathology and stress response in neurons precede programmed necrosis after neonatal hypoxia-ischemia201648587010.1016/j.ijdevneu.2015.11.0072-s2.0-849494835312664321284949483531InoueT.Suzuki-KarasakiY.Mitochondrial superoxide mediates mitochondrial and endoplasmic reticulum dysfunctions in TRAIL-induced apoptosis in Jurkat cells20136127328410.1016/j.freeradbiomed.2013.04.0202-s2.0-84878006508SinhaK.DasJ.PalP. B.SilP. C.Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis20138771157118010.1007/s00204-013-1034-42-s2.0-848791651602354300984879165160ShengR.LiuX. Q.ZhangL. S.GaoB.HanR.WuY. Q.ZhangX. Y.QinZ. H.Autophagy regulates endoplasmic reticulum stress in ischemic preconditioning201283310325GormanA. M.HealyS. J.JägerR.SamaliA.Stress management at the ER: regulators of ER stress-induced apoptosis2012134330631610.1016/j.pharmthera.2012.02.0032-s2.0-84859799949SzegezdiE.FitzgeraldU.SamaliA.Caspase-12 and ER-stress-mediated apoptosis: the story so far2003101018619410.1196/annals.1299.0322-s2.0-1342305497150337181342305497YoshidaH.OkadaT.HazeK.YanagiH.YuraT.NegishiM.MoriK.ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response200020186755676710.1128/MCB.20.18.6755-6767.20002-s2.0-0033815971109586730033815971CaiX. H.LiX. C.JinS. W.LiangD. S.WenZ. W.CaoH. C.MeiH. F.WuY.LinZ. D.WangL. X.Endoplasmic reticulum stress plays critical role in brain damage after chronic intermittent hypoxia in growing rats201425714815610.1016/j.expneurol.2014.04.0292-s2.0-849008490042481032184900849004PlacidoA. I.PereiraC. M.DuarteA. I.CandeiasE.CorreiaS. C.CarvalhoC.CardosoS.OliveiraC. R.MoreiraP. I.Modulation of endoplasmic reticulum stress: an opportunity to prevent neurodegeneration201514451853310.2174/1871527314666150429112353SateiaM. J.Neuropsychological impairment and quality of life in obstructive sleep apnea200324224925910.1016/S0272-5231(03)00014-52-s2.0-0038193900128007820038193900IncalziR. A.GemmaA.MarraC.MuzzolonR.CapparellaO.CarboninP.Chronic obstructive pulmonary disease. An original model of cognitive decline1993148241842410.1164/ajrccm/148.2.41883429060027304581Antonelli-IncalziR.CorsonelloA.PedoneC.TrojanoL.AcanforaD.SpadaA.IzzoO.RengoF.Drawing impairment predicts mortality in severe COPD200613061687169410.1378/chest.130.6.16872-s2.0-3384596219717166983OzgeC.OzgeA.UnalO.Cognitive and functional deterioration in patients with severe COPD200617212113010.1155/2006/8486071687392433746085173HungW. W.WisniveskyJ. P.SiuA. L.RossJ. S.Cognitive decline among patients with chronic obstructive pulmonary disease2009180213413710.1164/rccm.200902-0276OC2-s2.0-676507217841942371467650721784AlchanatisM.ZiasN.DeligiorgisN.AmfilochiouA.DionellisG.OrphanidouD.Sleep apnea-related cognitive deficits and intelligence: an implication of cognitive reserve theory2005141697510.1111/j.1365-2869.2004.00436.x2-s2.0-154443759851574333615444375985RaoB. S.RajuT. R.MetiB. L.Increased numerical density of synapses in CA3 region of hippocampus and molecular layer of motor cortex after self-stimulation rewarding experience199991379980310391463SprengelmeyerR.SteeleJ. D.MwangiB.KumarP.ChristmasD.MildersM.MatthewsK.The insular cortex and the neuroanatomy of major depression20111331-212012710.1016/j.jad.2011.04.0042-s2.0-800516717512153102780051671751RomanF. S.TruchetB.MarchettiE.ChaillanF. A.Soumireu-MouratB.Correlations between electrophysiological observations of synaptic plasticity modifications and behavioral performance in mammals1999581618710.1016/S0301-0082(98)00076-82-s2.0-0032895448103217970032895448MalenkaR. C.BearM. F.LTP and LTD: an embarrassment of riches200444152110.1016/j.neuron.2004.09.0122-s2.0-5344241223154501565344241223TangM.LiZ.ChenL.XingT.HuY.YangB.RuanD. Y.SunF.WangM.The effect of quantum dots on synaptic transmission and plasticity in the hippocampal dentate gyrus area of anesthetized rats200930284948495510.1016/j.biomaterials.2009.06.0122-s2.0-678491266441956403867849126644YangY.CalakosN.Presynaptic long-term plasticity20135810.3389/fnsyn.2013.000082-s2.0-8489427445824146648HarooniH. E.NaghdiN.SepehriH.RohaniA. H.The role of hippocampal nitric oxide (NO) on learning and immediate, short- and long-term memory retrieval in inhibitory avoidance task in male adult rats2009201116617210.1016/j.bbr.2009.02.0112-s2.0-648490979231942863064849097923YamadaK.NodaY.NakayamaS.KomoriY.SugiharaH.HasegawaT.NabeshimaT.Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain1995115585285810.1111/j.1476-5381.1995.tb15011.x2-s2.0-002903566885481870029035668KatzoffA.Ben-GedalyaT.SussweinA. J.Nitric oxide is necessary for multiple memory processes after learning that a food is inedible in aplysia2002222195819594KendrickK. M.Guevara-GuzmanR.ZorrillaJ.HintonM. R.BroadK. D.MimmackM.OhkuraS.Formation of olfactory memories mediated by nitric oxide1997388664367067410.1038/417652-s2.0-003075823492624000030758234BöhmeG. A.BonC.LemaireM.ReibaudM.PiotO.StutzmannJ. M.DobleA.BlanchardJ. C.Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats199390199191919410.1073/pnas.90.19.91912-s2.0-002742466476924450027424664SussweinA. J.KatzoffA.MillerN.HurwitzI.Nitric oxide and memory200410215316210.1177/10738584032612262-s2.0-1642282873ArancioO.KieblerM.LeeC. J.Lev-RamV.TsienR. Y.KandelE. R.HawkinsR. D.Nitric oxide acts directly in the presynaptic neuron to produce long-term potentiation in cultured hippocampal neurons19968761025103510.1016/S0092-8674(00)81797-32-s2.0-003058267489786070030582674SchumanE. M.MadisonD. V.A requirement for the intercellular messenger nitric oxide in long-term potentiation199125450371503150610.1126/science.172057217205720026326187ZhuoM.SmallS. A.KandelE. R.HawkinsR. D.Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus199326051161946195010.1126/science.810036881003680027267817WangX. X.ZhaY. Y.YangB.ChenL.WangM.Suppression of synaptic plasticity by fullerenol in rat hippocampus in vitro20161149474955MirkovS. M.DjordjevicA. N.AndricN. L.AndricS. A.KosticT. S.BogdanovicG. M.Vojinovic-MiloradovM. B.KovacevicR. Z.Nitric oxide-scavenging activity of polyhydroxylated fullerenol, C60(OH)24200411220120710.1016/j.niox.2004.08.0032-s2.0-5644292293154918535644292293WolffD. J.PapoiuA. D.MialkowskiK.RichardsonC. F.SchusterD. I.WilsonS. R.Inhibition of nitric oxide synthase isoforms by tris-malonyl-C(60)-fullerene adducts2000378221622310.1006/abbi.2000.18432-s2.0-0034660344108605390034660344XuL. H.XieH.ShiZ. H.Du LDW. Y. K.LiA. M.KeY.YungW. H.Critical role of endoplasmic reticulum stress in chronic intermittent hypoxia-induced deficits in synaptic plasticity and long-term memory201523969571010.1089/ars.2014.61222-s2.0-84942043077HarperR. M.KumarR.MaceyP. M.WooM. A.OgrenJ. A.Affective brain areas and sleep-disordered breathing2014209275293ZhangJ.MalikA.ChoiH. B.KoR. W.Dissing-OlesenL.MacVicarB. A.Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase201482119520710.1016/j.neuron.2014.01.0432-s2.0-848974016192463134484897401619ZhaoY. N.WangH. Y.LiJ. M.ChenB. Y.XiaG.ZhangP. P.GeY. L.Hippocampal mitogen-activated protein kinase activation is associated with intermittent hypoxia in a rat model of obstructive sleep apnea syndrome201613113714510.3892/mmr.2015.45052-s2.0-8495424113926549199SchröderM.KaufmanR. J.The mammalian unfolded protein response20057473978910.1146/annurev.biochem.73.011303.0741342-s2.0-222444465051595290222244446505van der VliesD.MakkinjeA. J. B. I.VerkleijA. J.WirtzK. W.PostJ. A.Oxidation of ER resident proteins upon oxidative stress: effects of altering cellular redox/antioxidant status and implications for protein maturation20035438138710.1089/152308603768295113DengW.Neurobiology of injury to the developing brain20106632833610.1038/nrneurol.2010.532-s2.0-779548650352047977977954865035InderT.HuppiP. S.ZientaraG. P.MaierS. E.JoleszF. A.di SalvoD.RobertsonR.BarnesP. D.VolpeJ. J.Early detection of periventricular leukomalacia by diffusion-weighted magnetic resonance imaging techniques1999134563163410.1016/S0022-3476(99)70251-9102283000033505891MaceyP. M.RichardC. A.KumarR.WooM. A.OgrenJ. A.AvedissianC.ThompsonP. M.HarperR. M.Hippocampal volume reduction in congenital central hypoventilation syndrome200947, article e6436CannonT. D.van ErpT. G.RossoI. M.HuttunenM.LönnqvistJ.PirkolaT.SalonenO.ValanneL.PoutanenV. P.Standertskjöld-NordenstamC. G.Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls2002591354110.1001/archpsyc.59.1.35117792800036137931CzéhB.LucassenP. J.What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated2007257525026010.1007/s00406-007-0728-02-s2.0-344471202901740172834447120290TreadwayM. T.WaskomM. L.DillonD. G.HolmesA. J.ParkM. T.ChakravartyM. M.DutraS. J.PolliF. E.IosifescuD. V.FavaM.GabrieliJ. D.PizzagalliD. A.Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression201577328529410.1016/j.biopsych.2014.06.0182-s2.0-849257186532510966584925718653KoenigsM.GrafmanJ.The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex2009201223924310.1016/j.bbr.2009.03.0042-s2.0-673491220311942864067349122031MillerE. K.CohenJ. D.An integrative theory of prefrontal cortex function20012416720210.1146/annurev.neuro.24.1.1672-s2.0-0034928713112833090034928713BuzsákiG.DraguhnA.Neuronal oscillations in cortical networks200430456791926192910.1126/science.10997452-s2.0-3042523540152181363042523540ColginL. L.Oscillations and hippocampal-prefrontal synchrony201121346747410.1016/j.conb.2011.04.0062-s2.0-799602265312157152279960226531SchwindelC. D.McNaughtonB. L.Hippocampal-cortical interactions and the dynamics of memory trace reactivation2011193163177SwansonL. W.A direct projection from Ammon’s horn to prefrontal cortex in the rat1981217115015410.1016/0006-8993(81)90192-X2-s2.0-001940781072606120019407810ThierryA. M.GioanniY.DégénétaisE.GlowinskiJ.Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics200010441141910.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A109852800033812808BrockmannM. D.KukovicM.SchönfeldM.SedlacikJ.Hanganu-OpatzI. L.Hypoxia-ischemia disrupts directed interactions within neonatal prefrontal-hippocampal networks2013812, article e8307424427797KimJ.WooJ.ParkY. G.ChaeS.JoS.ChoiJ. W.JunH. Y.YeomY. I.ParkS. H.KimK. H.ShinH. S.KimD.Thalamic T-type Ca2+ channels mediate frontal lobe dysfunctions caused by a hypoxia-like damage in the prefrontal cortex201131114063407310.1523/JNEUROSCI.4493-10.20112-s2.0-799527574942141164879952757494McEwenB. S.Physiology and neurobiology of stress and adaptation: central role of the brain200787387390410.1152/physrev.00041.20062-s2.0-344476293821761539134447629382SorrellsS. F.SapolskyR. M.An inflammatory review of glucocorticoid actions in the CNS200721325927210.1016/j.bbi.2006.11.0062-s2.0-338466613851719456533846661385SapolskyR. M.Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders2000571092593510.1001/archpsyc.57.10.925110158100033800486MiguelP. M.DenizB. F.DeckmannI.ConfortimH. D.DiazR.LaureanoD. P.SilveiraP. P.PereiraL. O.Prefrontal cortex dysfunction in hypoxic-ischaemic encephalopathy contributes to executive function impairments in rats: potential contribution for attention-deficit/hyperactivity disorder201711410.1080/15622975.2016.12735512810589585009971446LismanJ. E.Bursts as a unit of neural information: making unreliable synapses reliable1997201384310.1016/S0166-2236(96)10070-92-s2.0-003105992090044180031059920SharpF. R.BernaudinM.HIF1 and oxygen sensing in the brain20045643744810.1038/nrn1408151521942642555563ZhangM.WuJ.HuoL.LuoL.SongX.FanF.LuY.LiangD.Environmental enrichment prevent the juvenile hypoxia-induced developmental loss of parvalbumin-immunoreactive cells in the prefrontal cortex and neurobehavioral alterations through inhibition of NADPH oxidase-2-derived oxidative stress201653107341735010.1007/s12035-015-9656-62-s2.0-849518655912669858284951865591HasselmoM. E.McGaughyJ.High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation2004145207231RowB. W.LiuR.XuW.KheirandishL.GozalD.Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat2003167111548155310.1164/rccm.200209-1050OC2-s2.0-0038132134126156220038132134RowB. W.KheirandishL.ChengY.RowellP. P.GozalD.Impaired spatial working memory and altered choline acetyltransferase (CHAT) immunoreactivity and nicotinic receptor binding in rats exposed to intermittent hypoxia during sleep2007177230831410.1016/j.bbr.2006.11.0282-s2.0-338464238621721802333846423862CaulfieldM. P.BirdsallN. J.International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors19985022792909647869DouglasC. L.BaghdoyanH. A.LydicR.Prefrontal cortex acetylcholine release, EEG slow waves, and spindles are modulated by M2 autoreceptors in C57BL/6J mouse20028762817282212037184HambrechtV. S.VlisidesP. E.RowB. W.GozalD.BaghdoyanH. A.LydicR.G proteins in rat prefrontal cortex (PFC) are differentially activated as a function of oxygen status and PFC region200937211211710.1016/j.jchemneu.2008.12.0022-s2.0-585490994821911862158549099482BaxterM. G.MurrayE. A.The amygdala and reward20023756357310.1038/nrn8752-s2.0-0036634628120942120036634628TownsendJ.AltshulerL. L.Emotion processing and regulation in bipolar disorder: a review201214432633910.1111/j.1399-5618.2012.01021.x2-s2.0-848614896812263161884861489681ZouK.DengW.LiT.ZhangB.JiangL.HuangC.SunX.SunX.Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study201067218618810.1016/j.biopsych.2009.09.0142-s2.0-716491058281989717671649105828BellaniM.BaianoM.BrambillaP.Brain anatomy of major depression II. Focus on amygdala20112013336CartyM. L.WixeyJ. A.KesbyJ.ReinebrantH. E.ColditzP. B.GobeG.BullerK. M.Long-term losses of amygdala corticotropin-releasing factor neurons are associated with behavioural outcomes following neonatal hypoxia-ischemia2010208260961810.1016/j.bbr.2010.01.0072-s2.0-772491621332008578777249162133PetersonB. S.VohrB.StaibL. H.CannistraciC. J.DolbergA.SchneiderK. C.KatzK. H.WesterveldM.SparrowS.AndersonA. W.DuncanC. C.MakuchR. W.GoreJ. C.MentL. R.Regional brain volume abnormalities and long-term cognitive outcome in preterm infants2000284151939194710.1001/jama.284.15.1939110358900034684151BabovićS. S.ŽigićS.ŠakićB.c-fos protein expression in the anterior amygdaloid area and nc. accumbens in the hypoxic rat brain20146711-1237938410.2298/MPNS1412379B2567582884938538895HaukvikU. K.McNeilT.LangeE. H.MelleI.DaleA. M.AndreassenO. A.AgartzI.Pre- and perinatal hypoxia associated with hippocampus/amygdala volume in bipolar disorder2014445975985DeLeoJ. A.ApplegateC. D.BurchfielJ. L.LorenzoA. V.HsiD. H.Perinatal exposure to anoxia alone does not alter the susceptibility to amygdaloid-kindled seizures in the adult rabbit1990522116817110.1016/0006-8993(90)91596-92-s2.0-002536242922245130025362429KumarR.LeeK.MaceyP. M.WooM. A.HarperR. M.Mammillary body and fornix injury in congenital central hypoventilation syndrome200966442943410.1203/PDR.0b013e3181b3b3632-s2.0-703504418221958183170350441822KumarR.MaceyP. M.WooM. A.HarperR. M.Rostral brain axonal injury in congenital central hypoventilation syndrome201088102146215410.1002/jnr.223852-s2.0-779536346012020963177953634601MaceyP. M.WooM. A.MaceyK. E.KeensT. G.SaeedM. M.AlgerJ. R.HarperR. M.Hypoxia reveals posterior thalamic, cerebellar, midbrain, and limbic deficits in congenital central hypoventilation syndrome200598395896910.1152/japplphysiol.00969.20042-s2.0-1414425676315531561IbbotsonK.YellJ.RonaldsonP. T.Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress20171416ZhaiX.LinH.ChenY.ChenX.ShiJ.ChenO.LiJ.SunX.Hyperbaric oxygen preconditioning ameliorates hypoxia-ischemia brain damage by activating Nrf2 expression in vivo and in vitro201650445446610.3109/10715762.2015.11364112-s2.0-849603992152672962484960399215NikolaouK. E.Malamitsi-PuchnerA.BoutsikouT.EconomouE.BoutsikouM.PuchnerK. P.BakaS.HassiakosD.The varying patterns of neurotrophin changes in the perinatal period2006109242643310.1196/annals.1365.0412-s2.0-342472420931730816934247242093HuboldC.LangU. E.GehringH.SchultesB.SchweigerU.PetersA.HellwegR.OltmannsK. M.Increased serum brain-derived neurotrophic factor protein upon hypoxia in healthy young men2009116101221122510.1007/s00702-009-0257-22-s2.0-703492572701956518170349257270HelanM.AravamudanB.HartmanW. R.ThompsonM. A.JohnsonB. D.PabelickC. M.PrakashY. S.BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia201468899710.1016/j.yjmcc.2014.01.0062-s2.0-848942790682446283184894279068BoyadjievaN. I.SarkarD. K.Cyclic adenosine monophosphate and brain-derived neurotrophic factor decreased oxidative stress and apoptosis in developing hypothalamic neuronal cells: role of microglia20133781370137910.1111/acer.121042-s2.0-848809801602355080684880980160PooM. M.Neurotrophins as synaptic modulators200121243210.1038/350490042-s2.0-0035234670112533560035234670ScottA. L.ZhangM.NurseC. A.Enhanced BDNF signalling following chronic hypoxia potentiates catecholamine release from cultured rat adrenal chromaffin cells2015593153281329910.1113/JP2707252-s2.0-849381518252609597684938151825WangJ.ZhangS.MaH.YangS.LiuZ.WuX.WangS.ZhangY.LiuY.Chronic intermittent hypobaric hypoxia pretreatment ameliorates ischemia-induced cognitive dysfunction through activation of ERK1/2-CREB-BDNF pathway in anesthetized mice201742250151210.1007/s11064-016-2097-42-s2.0-849944159422782266884994415942DengR.ZhaoF. Y.ZhangL.LiD. Y.MuD. Z.Role of STAT3 signaling pathway in hypoxic-ischemic brain damage of neonatal rats2016181788426781418HristovaM.Rocha-FerreiraE.FontanaX.TheiL.BuckleR.ChristouM.HompoonsupS.GostelowN.RaivichG.PeeblesD.Inhibition of signal transducer and activator of transcription 3 (STAT3) reduces neonatal hypoxic-ischaemic brain damage2016136598199410.1111/jnc.134902-s2.0-849582136042666992784958213604ChenS. J.YangJ. F.KongF. P.RenJ. L.HaoK.LiM.YuanY.ChenX. C.YuR. S.LiJ. F.LengG.ChenX. Q.DuJ. Z.Overactivation of corticotropin-releasing factor receptor type 1 and aquaporin-4 by hypoxia induces cerebral edema201411136131991320410.1073/pnas.14044931112-s2.0-849069982202514669984906998220WeiB.LiL.HeA.ZhangY.SunM.XuZ.Hippocampal NMDAR-Wnt-catenin signaling disrupted with cognitive deficits in adolescent offspring exposed to prenatal hypoxia2016163115716410.1016/j.brainres.2015.11.0412-s2.0-849593873292665606784959387329ZhuM.LuM.LiQ. J.ZhangZ.WuZ. Z.LiJ.QianL.XuY.WangZ. Y.Hyperbaric oxygen suppresses hypoxic-ischemic brain damage in newborn rats2015301758210.1177/08830738145305002-s2.0-849216797252476286584921679725